Patients 75 years (Wegovy injection and placebo) reported more serious adverse reactions overall compared to younger adult patients Type 2 Diabetes: Wegovy tablets have not been studied for weight reduction in adults with T2D and obesity or overweight
Medication-specific injection site guidance While all GLP-1 medications use the same three injection sites, each medication has subtle differences worth considering when choosing your primary site
Strehlow K, Rotter S, Wassmann S, Adam O, Groh C, Laufs K, et al
Efficacy and safety of glucagon-like peptide-1 receptor agonist use during the first trimester in pregnant women with type 2 diabetes
Hospital-admitted datasets record all admissions to public hospitals, and were used to model the incidence of non-fatal hospitalisations for MI, stroke and HF [20]
Yammine, L